Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection.

ABSTRACT:

SUBMITTER: Banham GD 

PROVIDER: S-EPMC8729838 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature